Skip to main content

Table 1 Construct morphology and cellular content

From: Thyroid hormones enhance the biomechanical functionality of scaffold-free neocartilage

Group

  

Wet weight (mg)

Water content (%)

Diameter (mm)

Thickness (mm)

Cells (×10^6)

Phase 1

       
  

Control

32.9 ± 1.0AB

89.7 ± 2.3A

6.18 ± 0.14A

0.81 ± 0.15A

3.72 ± 0.45AB

 

Week 1 Treatment

PTH

33.9 ± 1.0A

89.4 ± 0.6A

6.09 ± 0.09A

0.77 ± 0.05A

3.57 ± 0.20AB

  

T3

17.1 ± 0.5C

85.0 ± 0.8B

5.66 ± 0.05B

0.54 ± 0.07B

3.10 ± 0.11BC

  

T4

17.8 ± 0.7C

85.3 ± 1.4B

5.80 ± 0.09B

0.53 ± 0.02B

2.87 ± 0.24C

 

Week 3 Treatment

PTH

31.5 ± 1.4B

88.3 ± 0.5A

6.28 ± 0.12A

0.69 ± 0.05A

3.54 ± 0.30AB

  

T3

32.8 ± 1.0AB

87.8 ± 0.6A

6.24 ± 0.05A

0.72 ± 0.05A

3.60 ± 0.26AB

  

T4

33.0 ± 1.3AB

88.3 ± 0.8A

6.18 ± 0.09A

0.74 ± 0.03A

3.71 ± 0.30A

Phase 2

       
 

No T3 Treatment

Control

15.4 ± 0.6a

89.5 ± 0.5a

5.65 ± 0.13ab

0.56 ± 0.05ab

2.85 ± 0.27a

  

PTH Week 2

16.6 ± 1.5a

89.6 ± 0.6a

5.71 ± 0.10ab

0.61 ± 0.04a

3.00 ± 0.21a

  

PTH Week 3

16.1 ± 0.5a

89.4 ± 0.3a

5.71 ± 0.08ab

0.60 ± 0.03a

3.01 ± 0.20a

  

PTH Week 2-4

16.2 ± 0.5a

89.1 ± 0.4a

5.80 ± 0.09a

0.85 ± 0.03ab

2.74 ± 0.47a

 

Week 1 T3 Treatment

No PTH

13.4 ± 0.9b

84.9 ± 1.0b

5.67 ± 0.12ab

0.55 ± 0.08ab

2.71 ± 0.24a

  

PTH Week 2

14.0 ± 0.7b

84.9 ± 0.6b

5.69 ± 0.23ab

0.57 ± 0.04ab

2.98 ± 0.15a

  

PTH Week 3

13.1 ± 0.8b

85.6 ± 0.9b

5.53 ± 0.09b

0.59 ± 0.11ab

2.91 ± 0.19a

  

PTH Week 2-4

13.3 ± 0.6b

84.7 ± 0.6b

5.60 ± 0.16ab

0.49 ± 0.04b

2.72 ± 0.17a

  1. Phase 1 and 2 construct morphology and cellular content. Phase 2 used a lower seeding density (for example, 4.57 versus 5.32 million cells in Phase 1) and resulted in smaller constructs. Letters represent the statistical results of a one-way and two-way ANOVA for Phase 1 and 2, respectively. Groups not connected by the same letter are statistically significant. Data are represented as mean ± standard deviation.